Potentiated Vaccine 

for Global Immunization

Company motto

  • Potentiates vaccine for global immunization
  • No child left alone without vaccine 

Vision statement 

  • Innovative technology for novel vaccine 
  • Cold chain free nasal vaccine 
  • Peptide vaccine without pathogen 
  • Low cost T-Cell therapy for cancer and infectious disease

What NA Vaccine Institute has

  • An adjuvant for potentiated vaccine 
  • An adjuvant for both parenteral and mucosal vaccination
  • An adjuvant with a potent cell mediated immunity for cancer vaccines 
  • The cost effective production system for the adjuvant 
  • Produces 100K dose of the adjuvant in less than a month

What NA Vaccine Institute does

Adjuvant related business; 

Licensing out of the vaccine adjuvant and/or contract research for the adjuvant development

  • Development of adjuvant for more potentiated but safer vaccines
  • Development for adjuvant for more effective parentreal and mucosal vaccine
  • Development for adjuvant for oral or nasal vaccine

Vaccine development; 

Own internal programs and collaboration with others

  • Nasal flu vaccine with a broad spectrum protection
  • Nasal vaccine without a medical staff 
  • Vaccine without cold chain 
  • Peptide based vaccine
  • Neoantigenic cancer vaccine 

Where NA Vaccine Institute is heading to

  • Development of novel adjuvant and enhanced vaccine for global immunization with lower cost and risk.
  • Vaccines with the breakthrough features of the broad spectrum specificity by intradermal, oral, or nasal delivery routes.
  • Vaccines with reduce cost and improve efficacy without  cold chain 
  • Peptide vaccines without pathogen 
  • Setting up the industrial standard for the production of the novel adjuvant molecule, the industrial scale production, and QC guide line for each production steps.